Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.hester.in | |
Market Cap | 1,432.47 Cr. | |
Enterprise Value(EV) | 1,685.81 Cr. | 2023-03 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 33.54 | Trailing Twelve Months Ending 2023-06 |
Price-Earning Ratio (PE) | 50.19 | Trailing Twelve Months Ending 2023-06 |
Industry PE | 37.52 | Trailing Twelve Months Ending 2023-06 |
Book Value / Share | 335.10 | Trailing Twelve Months Ending 2023-06 |
Price to Book Value | 5.02 | Calculated using Price: 1,683.30 |
Dividend Yield | 0.48 | Period Ending 2023-03 |
No. of Shares Subscribed | 0.85 Cr. | 8,506,865 Shares |
FaceValue | 10 | |
About Hester Biosciences Ltd. | ||
Hester Biosciences was incorporated on April 29, 1987 as a Private Limited Company by the name of Hester Pharmaceuticals Limited. It was subsequently converted into a Public Limited Company on November 1, 1993. The company is engaged in the manufacturing of poultry vaccines. The company has been promoted by Rajiv D. Gandhi his brother Sanjiv D. Gandhi and Dr. Bhupendra V. Gandhi. The company changed its name to the present in 2008. |
1 Day |
|
+0.60% |
1 Week |
|
-0.26% |
1 Month |
|
-0.52% |
3 Month |
|
-1.43% |
6 Month |
|
+2.38% |
1 Year |
|
-17.62% |
2 Year |
|
-33.01% |
5 Year |
|
+50.29% |
10 Year |
|
+1458.61% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 16.73 | 20.56 | 20.38 | 17.57 | 25.59 | 16.38 | 16.16 | 16.17 | 10.39 | |
Return on Capital Employed (%) | 17.26 | 18.98 | 19.75 | 20.20 | 26.64 | 16.53 | 17.33 | 14.12 | 9.60 | |
Return on Assets (%) | 8.84 | 11.08 | 11.43 | 10.10 | 14.97 | 9.04 | 8.70 | 8.11 | 4.55 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Shh. Funds | 75 | 85 | 102 | 122 | 141 | 177 | 201 | 228 | 260 | 280 | |
Non Curr. Liab. | 20 | 38 | 41 | 48 | 44 | 70 | 97 | 114 | 198 | 233 | |
Curr. Liab. | 45 | 35 | 38 | 38 | 55 | 49 | 83 | 61 | 97 | 149 | |
Minority Int. | 1 | 3 | 5 | 5 | 4 | 4 | 5 | 8 | 7 | 9 | |
Equity & Liab. | 142 | 160 | 186 | 213 | 244 | 299 | 387 | 411 | 562 | 670 | |
Non Curr. Assets | 85 | 100 | 112 | 133 | 146 | 158 | 227 | 250 | 367 | 442 | |
Curr. Assets | 57 | 60 | 74 | 80 | 98 | 142 | 159 | 162 | 195 | 228 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 142 | 160 | 186 | 213 | 244 | 299 | 387 | 411 | 562 | 670 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-06 Rs. Cr. TTM |
Net Sales | 90 | 101 | 123 | 136 | 178 | 183 | 214 | 235 | 266 | 303 | |
Other Income | 0 | 1 | 0 | 3 | 7 | 6 | 5 | 14 | 15 | 13 | |
Total Income | 90 | 102 | 124 | 138 | 185 | 190 | 219 | 249 | 281 | 316 | |
Total Expenditure | -65 | -68 | -82 | -89 | -110 | -128 | -146 | -175 | -216 | -246 | |
PBIDT | 26 | 34 | 41 | 50 | 75 | 62 | 73 | 74 | 66 | 71 | |
Interest | -5 | -4 | -4 | -4 | -7 | -7 | -7 | -4 | -9 | -10 | |
Depreciation | -6 | -6 | -7 | -10 | -12 | -13 | -13 | -17 | -21 | -21 | |
Taxation | -5 | -6 | -8 | -13 | -16 | -10 | -15 | -14 | -12 | -12 | |
Exceptional Items | 3 | -3 | |||||||||
PAT | 13 | 19 | 23 | 23 | 41 | 31 | 35 | 39 | 28 | 27 | |
Minority Interest | 0 | 0 | 1 | 3 | 1 | -2 | 0 | 0 | -1 | -3 | |
Share Associate | 4 | ||||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | 14 | 19 | 24 | 26 | 42 | 29 | 34 | 39 | 27 | 29 | |
Adjusted EPS | 16 | 23 | 28 | 30 | 49 | 34 | 40 | 46 | 31 | 34 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 9 | 20 | 19 | 35 | 38 | 47 | 37 | 58 | 9 | 24 | |
Cash Fr. Inv. | -15 | -21 | -13 | -30 | -26 | -22 | -74 | -38 | -117 | -77 | |
Cash Fr. Finan. | 7 | 7 | -7 | 2 | -11 | 3 | 19 | -18 | 112 | 42 | |
Net Change | 2 | 5 | -1 | 6 | 1 | 28 | -19 | 1 | 4 | -12 | |
Cash & Cash Eqvt | 4 | 6 | 5 | 11 | 12 | 41 | 24 | 21 | 25 | 13 |
Mon, 25 Sep 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation of Loss of Share Certificate request received from the shareholder |
Wed, 20 Sep 2023
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report Scrutinizer report and Voting results of 36th Annual General Meeting |
Wed, 20 Sep 2023
Shareholder Meeting / Postal Ballot-Outcome of AGM Outcome of 36th Annual General Meeting held on 20 September 2023 which includes Proceedings Voting Results and Scrutinizer Report. |
Thu, 28 Sep 2023 |
|
|
|
Wed, 27 Sep 2023 |
|
|